Comment on “Superiority of the Rockwood Clinical Frailty Scale for Assessing Long‐Term Outcome in Patients Undergoing Transcatheter Aortic Valve Implantation”

We read with interest the study by Bagnall et al., which compares three frailty indices in a large transcatheter aortic valve implantation (TAVI) cohort with extended 5-year follow-up 1. The authors provide valuable long-term observational data in an area where the durability of prognostic markers remains clinically relevant. Several methodological and translational considerations may further refine interpretation and support clinical application of the findings. A key consideration relates to the overall discriminatory performance of the multivariable models. Although the Rockwood Clinical Frailty Scale (CFS) demonstrated statistically superior discrimination compared with the Karnofsky and Katz indices, the absolute area under the curve remained modest (AUC = 0.59). This observation suggests that frailty, while prognostically informative, functions primarily as a contributory risk marker rather than a standalone discriminator of long-term outcome in contemporary TAVI populations. Framing frailty within a broader, integrative risk assessment paradigm may therefore better reflect its clinical utility. Another methodological aspect concerns the categorization of frailty indices into tertiles for survival analysis. Transforming ordinal or continuous variables into grouped categories is known to reduce statistical power, obscure nonlinear associations, and introduce residual confounding across risk strata 2. This approach may attenuate the true gradient of risk conveyed by frailty severity, particularly for scales such as the Rockwood CFS that are designed to capture incremental clinical vulnerability 3. Well-established methodological literature has cautioned against categorization of continuous predictors for these reasons 4. Preserving scale continuity through alternative modeling strategies could enhance interpretability without altering clinical intent. The exclusive focus on all-cause mortality also limits translational interpretation. Frailty influences outcomes beyond survival, including functional recovery, mobility, institutionalization, and health-related quality of life. In older, multimorbid patients, these patient-centered endpoints often determine whether TAVI confers meaningful benefit 5. Aligning frailty strata with postprocedural functional trajectories may further clarify how frailty assessment should inform periprocedural planning, rehabilitation strategies, and Heart Team deliberations. Finally, the extended inclusion period spanning multiple device generations and procedural paradigms warrants careful contextualization. Advances in valve technology, access strategies, and periprocedural care during this interval may influence the strength and consistency of frailty–outcome associations. Accounting for temporal evolution in practice may help delineate whether observed prognostic relationships are stable across eras or modified by contemporary procedural refinements. In summary, Bagnall et al. contribute important long-term data supporting the prognostic relevance of frailty in TAVI candidates and reinforce the relative performance of the Rockwood CFS among commonly used indices. Further attention to variable modeling, patient-centered outcomes, and temporal context may enhance the integration of frailty assessment into routine clinical decision-making and optimize its role within multidisciplinary TAVI evaluation. Generative artificial intelligence (AI) use statement: Generative AI tools, including Paperpal and ChatGPT-4o, were utilized solely for language, grammar, and stylistic refinement. These tools had no role in the conceptualization, data analysis, interpretation of results, or substantive content development of this manuscript. All intellectual contributions, data analysis, and scientific interpretations remain the sole work of the authors. The final content was critically reviewed and edited to ensure accuracy and originality. The authors take full responsibility for the accuracy, originality, and integrity of the work presented. The authors received no specific funding for this work. The authors have nothing to report. Not applicable as no patient data were collected or analyzed in this study. The authors declare no conflicts of interest. Not applicable, as no data were generated or analyzed in this study.